Table 1.
Clinicopathological characteristics of patient samples and expression of AEG-1 in salivary gland cancer
| All cases (%) | All cases (%) | ||
|---|---|---|---|
| Gender | Histological Types | ||
| Male | 77 (54.61) | Mucoepidermoid carcinoma | 34 (24.11) |
| Female | 64 (45.39) | Adenoid cystic carcinoma | 20 (14.18) |
| Age (years) | Acinar cell carcinoma | 21 (14.89) | |
| < 48 | 72 (51.06) | Adenocarcinoma | 23 (16.31) |
| ≥ 48 | 69 (48.94) | Squamous cell carcinoma | 12 (8.51) |
| Clinical Stage | Salivary duct carcinoma | 16 (11.35) | |
| I | 16 (11.35) | Basal cell carcinoma | 15 (10.64) |
| II | 49 (34.75) | Vital status (at follow-up) | |
| III | 34 (24.11) | Alive | 95 (67.38) |
| IV | 42 (29.79) | Death (all SGC-related) | 46 (32.62) |
| T classification | Expression of AEG-1 | ||
| T1 | 17 (12.06) | Negative | 5 (3.55) |
| T2 | 60 (42.55) | Positive | 136 (96.45) |
| T3 | 33 (23.40) | Low expression | 62 (43.97) |
| T4 | 31 (21.99) | High expression | 79 (56.03) |
| N classification | Drinking | ||
| N0 | 106 (75.18) | No | 117 (82.98) |
| N1 | 17 (12.06) | Yes | 24 (17.02) |
| N2 | 18 (12.77) | Smoking | |
| M classification | No | 101 (71.63) | |
| No | 99 (70.21) | Yes | 40 (28.37) |
| Yes | 42 (29.79) |